Related Experiment Video
Updated: Aug 11, 2026

Particle Agglutination Method for Poliovirus Identification
Published on: April 20, 2011
[The microagglutination test--a simple and sensitive procedure for serodiagnosis of pertussis infections]
U Heininger1, K Stehr, S Schmitt-Grohe
1Universitätsklinik für Kinder und Jugendliche, Erlangen.
Abstract:
The microagglutination assay is a useful method for the diagnosis of B. pertussis infections. In a group of 30 patients with culture proven pertussis 27 (90%) had > or = fourfold increases in titers between acute and convalescent phase serum specimens. The microagglutination test offers several advantages over other more sophisticated B. pertussis antibody tests: only 50 microliters of serum is required, it is a standardized test, which doesn't require specialized technical expertise or equipment, it is easy to perform and good results are noted in a broad age range of patients. Disadvantages of the microagglutination test are: two separate serum specimens are necessary (acute and convalescent phase), the test does not differentiate IgA and IgG antibodies and the temporal association with recent immunization can lead to false positive results. In our opinion the microagglutination test is a useful method for the diagnosis of B. pertussis infections. This is especially true in cases where more sophisticated serologic tests such as ELISA can not be performed immediately but physicians and patients expect to get a result quickly.
Insights
The microagglutination assay is a valuable tool for diagnosing whooping cough (Bordetella pertussis) infections, showing high accuracy in patients with confirmed cases. This simple test provides rapid results when advanced methods are unavailable.
Area of Science:
- Microbiology
- Immunology
- Infectious Diseases
Background:
- Pertussis, caused by Bordetella pertussis, remains a significant public health concern.
- Accurate and timely diagnosis is crucial for effective patient management and disease control.
- Existing serological tests for B. pertussis antibodies have varying levels of complexity and accessibility.
Purpose of the Study:
- To evaluate the diagnostic utility of the microagglutination assay for detecting B. pertussis infections.
- To compare the advantages and disadvantages of the microagglutination test with other serological methods.
Main Methods:
- The study involved 30 patients with culture-proven pertussis.
- Paired acute and convalescent serum specimens were analyzed using the microagglutination assay.
- Titers were compared between the two serum phases to assess diagnostic sensitivity.
Main Results:
- A significant fourfold or greater increase in microagglutination titers was observed in 90% (27/30) of patients with confirmed pertussis.
- The assay requires minimal serum volume (50 microliters) and is standardized, requiring no specialized equipment or expertise.
- The test is easy to perform, effective across a broad age range, and provides rapid results.
Conclusions:
- The microagglutination assay is a practical and effective method for diagnosing B. pertussis infections.
- Its ease of use and speed make it particularly useful in settings where advanced serological tests like ELISA are not immediately available.
- Potential limitations include the need for paired sera and the inability to differentiate antibody isotypes (IgA, IgG), with recent immunization potentially causing false positives.

